NEW YORK (GenomeWeb) – Measuring the microdiversity in the tumors of children treated with chemotherapy could help predict which kids are more likely to see their cancer progress and could potentially guide more personalized treatment strategies for at least some childhood cancers, new data has shown.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.